Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial.
<h4>Background</h4>Atrial Fibrillation After Cardiac Surgery (AFACS) occurs in about one in three patients following Coronary Artery Bypass Grafting (CABG). It is associated with increased short- and long-term morbidity, mortality and costs. To reduce AFACS incidence, efforts are often m...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296525&type=printable |
| _version_ | 1797242855580762112 |
|---|---|
| author | Niall G Campbell Elizabeth Allen Richard Evans Zahra Jamal Charles Opondo Julie Sanders Joanna Sturgess Hugh E Montgomery Diana Elbourne Benjamin O'Brien |
| author_facet | Niall G Campbell Elizabeth Allen Richard Evans Zahra Jamal Charles Opondo Julie Sanders Joanna Sturgess Hugh E Montgomery Diana Elbourne Benjamin O'Brien |
| author_sort | Niall G Campbell |
| collection | DOAJ |
| description | <h4>Background</h4>Atrial Fibrillation After Cardiac Surgery (AFACS) occurs in about one in three patients following Coronary Artery Bypass Grafting (CABG). It is associated with increased short- and long-term morbidity, mortality and costs. To reduce AFACS incidence, efforts are often made to maintain serum potassium in the high-normal range (≥ 4.5mEq/L). However, there is no evidence that this strategy is efficacious. Furthermore, the approach is costly, often unpleasant for patients, and risks causing harm. We describe the protocol of a planned randomized non-inferiority trial to investigate the impact of intervening to maintain serum potassium ≥ 3.6 mEq/L vs ≥ 4.5 mEq/L on incidence of new-onset AFACS after isolated elective CABG.<h4>Methods</h4>Patients undergoing isolated CABG at sites in the UK and Germany will be recruited, randomized 1:1 and stratified by site to protocols maintaining serum potassium at either ≥ 3.6 mEq/L or ≥ 4.5 mEq/L. Participants will not be blind to treatment allocation. The primary endpoint is AFACS, defined as an episode of atrial fibrillation, flutter or tachycardia lasting ≥ 30 seconds until hour 120 after surgery, which is both clinically detected and electrocardiographically confirmed. Assuming a 35% incidence of AFACS in the 'tight control group', and allowing for a 10% loss to follow-up, 1684 participants are required to provide 90% certainty that the upper limit of a one-sided 97.5% confidence interval (CI) will exclude a > 10% difference in favour of tight potassium control. Secondary endpoints include mortality, use of hospital resources and incidence of dysrhythmias not meeting the primary endpoint (detected using continuous heart rhythm monitoring).<h4>Discussion</h4>The Tight K Trial will assess whether a protocol to maintain serum potassium ≥ 3.6 mEq/L is non inferior to maintaining serum potassium ≥ 4.5 mEq/L in preventing new-onset AFACS after isolated CABG.<h4>Trial registration</h4>ClinicalTrials.gov Identifier: NCT04053816. Registered on 13 August 2019. Last update 7 January 2021. |
| first_indexed | 2024-04-24T18:45:51Z |
| format | Article |
| id | doaj.art-f157da61f17544c398ea99c233e10554 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-24T18:45:51Z |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-f157da61f17544c398ea99c233e105542024-03-27T05:32:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01193e029652510.1371/journal.pone.0296525Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial.Niall G CampbellElizabeth AllenRichard EvansZahra JamalCharles OpondoJulie SandersJoanna SturgessHugh E MontgomeryDiana ElbourneBenjamin O'Brien<h4>Background</h4>Atrial Fibrillation After Cardiac Surgery (AFACS) occurs in about one in three patients following Coronary Artery Bypass Grafting (CABG). It is associated with increased short- and long-term morbidity, mortality and costs. To reduce AFACS incidence, efforts are often made to maintain serum potassium in the high-normal range (≥ 4.5mEq/L). However, there is no evidence that this strategy is efficacious. Furthermore, the approach is costly, often unpleasant for patients, and risks causing harm. We describe the protocol of a planned randomized non-inferiority trial to investigate the impact of intervening to maintain serum potassium ≥ 3.6 mEq/L vs ≥ 4.5 mEq/L on incidence of new-onset AFACS after isolated elective CABG.<h4>Methods</h4>Patients undergoing isolated CABG at sites in the UK and Germany will be recruited, randomized 1:1 and stratified by site to protocols maintaining serum potassium at either ≥ 3.6 mEq/L or ≥ 4.5 mEq/L. Participants will not be blind to treatment allocation. The primary endpoint is AFACS, defined as an episode of atrial fibrillation, flutter or tachycardia lasting ≥ 30 seconds until hour 120 after surgery, which is both clinically detected and electrocardiographically confirmed. Assuming a 35% incidence of AFACS in the 'tight control group', and allowing for a 10% loss to follow-up, 1684 participants are required to provide 90% certainty that the upper limit of a one-sided 97.5% confidence interval (CI) will exclude a > 10% difference in favour of tight potassium control. Secondary endpoints include mortality, use of hospital resources and incidence of dysrhythmias not meeting the primary endpoint (detected using continuous heart rhythm monitoring).<h4>Discussion</h4>The Tight K Trial will assess whether a protocol to maintain serum potassium ≥ 3.6 mEq/L is non inferior to maintaining serum potassium ≥ 4.5 mEq/L in preventing new-onset AFACS after isolated CABG.<h4>Trial registration</h4>ClinicalTrials.gov Identifier: NCT04053816. Registered on 13 August 2019. Last update 7 January 2021.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296525&type=printable |
| spellingShingle | Niall G Campbell Elizabeth Allen Richard Evans Zahra Jamal Charles Opondo Julie Sanders Joanna Sturgess Hugh E Montgomery Diana Elbourne Benjamin O'Brien Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial. PLoS ONE |
| title | Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial. |
| title_full | Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial. |
| title_fullStr | Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial. |
| title_full_unstemmed | Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial. |
| title_short | Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial. |
| title_sort | impact of maintaining serum potassium concentration ≥ 3 6meq l versus ≥ 4 5meq l for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation protocol for a randomized non inferiority trial |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296525&type=printable |
| work_keys_str_mv | AT niallgcampbell impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT elizabethallen impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT richardevans impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT zahrajamal impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT charlesopondo impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT juliesanders impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT joannasturgess impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT hughemontgomery impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT dianaelbourne impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial AT benjaminobrien impactofmaintainingserumpotassiumconcentration36meqlversus45meqlfor120hoursafterisolatedcoronaryarterybypassgraftsurgeryonincidenceofnewonsetatrialfibrillationprotocolforarandomizednoninferioritytrial |